Publications by authors named "Jennifer Spratlin"

Claim this Profile
T
The Tumor Immune Microenvironment Drives Survival Outcomes and Therapeutic Response in an Integrated Molecular Analysis of Gastric Adenocarcinoma.
Daniel Skubleny, Kieran Purich, David R McLean, Sebastiao N Martins-Filho, Klaus Buttenschoen, Jennifer L Spratlin

Clin Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-human phase I trial of daily oral zelenirstat, a N-myristoyltransferase inhibitor, in patients with advanced solid tumors and relapsed/refractory B-cell lymphomas.
Randeep Sangha, Rahima Jamal, Jennifer Spratlin, John Kuruvilla, Laurie H Sehn

Invest New Drugs· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feature-specific quantile normalization and feature-specific mean-variance normalization deliver robust bi-directional classification and feature selection performance between microarray and RNAseq data.
Daniel Skubleny, Sunita Ghosh, Jennifer Spratlin, Daniel E Schiller, Gina R Rayat

BMC Bioinformatics· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individual Survival Distributions Generated by Multi-Task Logistic Regression Yield a New Perspective on Molecular and Clinical Prognostic Factors in Gastric Adenocarcinoma.
Daniel Skubleny, Jennifer Spratlin, Sunita Ghosh, Russell Greiner, Daniel E Schiller

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies.
Chia-Chi Lin, Elena Garralda, Patrick Schöffski, David S Hong, Lillian L Siu, Jennifer Spratlin

Oncoimmunology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study.
Daniel Skubleny, Andrea Lin, Saurabh Garg, Ross McLean, Michael McCall, Jennifer L Spratlin

World J Gastrointest Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murine and Human Gastric Tissue Establishes Organoids after 48 Hours of Cold Ischemia Time during Shipment.
Daniel Skubleny, Saurabh Garg, Jim Wickware, Kieran Purich, Sunita Ghosh, Jennifer Spratlin

Biomedicines· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinoma.
Dylan E O'Sullivan, Devon J Boyne, Iqra A Syed, Cal Shephard, Derek L Clouthier, Jennifer L Spratlin

Can Liver J· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing Rates of Goals of Care Designations in Patients With Advanced Pancreatic Cancer During a Multifactorial Advanced Care Planning Initiative: A Real-World Evidence Study.
Matthew Anaka, Minji Lee, Elisa Lim, Sunita Ghosh, Winson Y Cheung, Jennifer Spratlin

JCO Oncol Pract· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel, First-in-Human, Oral PCLX-001 Treatment in a Patient with Relapsed Diffuse Large B-Cell Lymphoma.
Randeep Sangha, Neal M Davies, Afshin Namdar, Michael Chu, Jennifer Spratlin

Curr Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of dose-capping chemotherapy in concurrent chemoradiotherapy in rectal cancer patients.
Ran Yang, Moftah Younis, Kurian Joseph, Sunita Ghosh, Tirath Nijjar, Jennifer Spratlin

J Oncol Pharm Pract· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world patterns of adjuvant chemotherapy treatment for patients with resected pancreatic adenocarcinoma.
Omar Abdel-Rahman, Jennifer Spratlin, Sheryl Koski

Med Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Population-Based Retrospective Study of Biliary Tract Cancers in Alberta, Canada.
Carissa Beaulieu, Arthur Lui, Dimas Yusuf, Zainab Abdelaziz, Brock Randolph, Jennifer L Spratlin

Curr Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin and herbal supplements' use among patients with advanced gastrointestinal cancers included in eight clinical trials.
Omar Abdel-Rahman, Jennifer Spratlin, Sheryl Koski

J Cancer Res Clin Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of Resting Energy Expenditure Predictive Equations in Patients With Cancer.
Sarah A Purcell, Sarah A Elliott, Vickie E Baracos, Quincy S C Chu, Michael B Sawyer, Jennifer L Spratlin

Nutr Clin Pract· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Outcomes Among Patients Treated With Gemcitabine-based Therapy Post-FOLFIRINOX Failure in Advanced Pancreatic Cancer.
Erica S Tsang, Jennifer Spratlin, Winson Y Cheung, Christina A Kim, Shiying Kong

Am J Clin Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive and Prognostic Properties of Human Equilibrative Nucleoside Transporter 1 Expression in Gemcitabine-Treated Pancreatobiliary Cancer: A Meta-Analysis.
Larissa J Vos, Dimas Yusuf, Arthur Lui, Zainab Abdelaziz, Sunita Ghosh, Jennifer L Spratlin

JCO Precis Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged Response to Regorafenib in a Patient with Iodine Refractory Thyroid Cancer.
Selina K Wong, Quincy S C Chu, Jennifer L Spratlin, Randeep Sangha, Alexander J B McEwan

Case Rep Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study.
Asim Amin, Elizabeth R Plimack, Marc S Ernstoff, Lionel D Lewis, Todd M Bauer, Jennifer Spratlin

J Immunother Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of proximity to specialty care on outcomes for biliary cancers: a population-based retrospective cohort study.
Yuan Xu, Sue Steckle, Arthur Lui, Elijah Dixon, Chad G Ball, Jennifer Spratlin

CMAJ Open· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study.
Asim Amin, Elizabeth R Plimack, Marc S Ernstoff, Lionel D Lewis, Todd M Bauer, Jennifer Spratlin

J Immunother Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Impact of Clinical Benefit in Chemotherapy-treated Advanced Pancreatic Cancer Patients in Northern Alberta.
Christina A Kim, Quincy S C Chu, Konrad Fassbender, Sunita Ghosh, Jennifer L Spratlin

Am J Clin Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicentre, open-label phase II study of Irinotecan, capecitabine (Xeloda®), and Oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma.
Arthur Lui, Karen Mulder, Christine Brezden-Masley, Michael Vickers, Jose Monzon, Jennifer Spratlin

Invest New Drugs· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Impact of CAPOX Versus FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer.
Jonathan M Loree, Aaron Sha, Maryam Soleimani, Hagen F Kennecke, Maria Y Ho, Jennifer L Spratlin

Clin Colorectal Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study.
Hans J Hammers, Elizabeth R Plimack, Jeffrey R Infante, Brian I Rini, David F McDermott, Jennifer Spratlin

J Clin Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis